Rebecca L Wedel

Title: Rebecca L Wedel: Innovator in Pharmaceutical Formulations

Introduction

Rebecca L Wedel is a prominent inventor based in Lawrence, KS (US). She has made significant contributions to the field of pharmaceutical formulations, holding a total of 6 patents. Her work focuses on improving the stability and efficacy of medications, particularly through innovative compositions.

Latest Patents

One of her latest patents involves formulations containing clopidogrel and sulfoalkyl ether cyclodextrin (SAE-CD). This invention provides compositions that can be in liquid, suspension, or solid forms, suitable for oral, peroral, or parenteral administration. The SAE-CD plays a crucial role in enhancing the dissolution and stabilization of clopidogrel in aqueous media. The stability of clopidogrel against hydrolytic, thermal, and photolytic degradation is significantly improved with this formulation. The SAE-CD-containing compositions can be prepared in various forms, including ready-to-use and concentrated liquids, offering substantial pharmacokinetic and therapeutic advantages over traditional tablet compositions.

Career Highlights

Rebecca is currently associated with Cydex Pharmaceuticals, Inc., where she continues to innovate in the pharmaceutical sector. Her work has been instrumental in developing formulations that enhance drug delivery and effectiveness.

Collaborations

She has collaborated with notable colleagues, including Gerold L Mosher and Karen T Johnson, contributing to a dynamic research environment that fosters innovation.

Conclusion

Rebecca L Wedel's contributions to pharmaceutical formulations exemplify the impact of innovative thinking in medicine. Her patents reflect a commitment to improving drug stability and efficacy, ultimately benefiting patient care.